SPHK1 and plasma cell myeloma: Furthermore, through suppression of RTK phosphorylation and activation of death-associated protein kinase 1, the SphK1 inhibitor safingol synergistically sensitized EGCG-induced proapoptotic cell death and tumor suppression in multiple myeloma cells (DAPK1) [220].